|
Originally published In Press as doi:10.1074/jbc.M010873200 on April 13, 2001
J. Biol. Chem., Vol. 276, Issue 25, 23018-23027, June 22, 2001
An araC-controlled Bacterial
cre Expression System to Produce DNA Minicircle Vectors for
Nuclear and Mitochondrial Gene Therapy*
Brian W.
Bigger ,
Oleg
Tolmachov,
Jean-Marc
Collombet,
Michalis
Fragkos,
Iwona
Palaszewski, and
Charles
Coutelle
From the Cystic Fibrosis Gene Therapy Group, Division of Biomedical
Sciences, SAF Bldg., Imperial College of Science, Technology and
Medicine, Exhibition Rd., London SW7 2AZ, United Kingdom
The presence of CpG motifs and their associated
sequences in bacterial DNA causes an immunotoxic response following the
delivery of these plasmid vectors into mammalian hosts. We describe a
biotechnological approach to the elimination of this problem by the
creation of a bacterial cre recombinase expression system,
tightly controlled by the arabinose regulon. This permits the
Cre-mediated and -directed excision of the entire bacterial
vector sequences from plasmid constructs to create supercoiled gene
expression minicircles for gene therapy. Minicircle yields using
standard culture volumes are sufficient for most in vitro
and in vivo applications whereas minicircle expression
in vitro is significantly increased over standard plasmid
transfection. By the simple expedient of removing the bacterial DNA
complement, we significantly reduce the size and CpG content of these
expression vectors, which should also reduce DNA-induced inflammatory
responses in a dose-dependent manner. We further describe
the generation of minicircle expression vectors for mammalian
mitochondrial gene therapy, for which no other vector systems currently
exist. The removal of bacterial vector sequences should permit
appropriate transcription and correct transcriptional cleavage from the
mitochondrial minicircle constructs in a mitochondrial environment and
brings the realization of mitochondrial gene therapy a step closer.
*
This work was supported by the Medical Research Council,
The March of Dimes Birth Defects Foundation, and the Association Française de Lutte Centre la Mucoviscidose.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Fax: 0207-594-3015;
E-mail: b.bigger@ic.ac.uk.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Wu, X. Xiao, P. Zhao, G. Xue, Y. Zhu, X. Zhu, L. Zheng, Y. Zeng, and W. Huang
Minicircle-IFN{gamma} Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma
Clin. Cancer Res.,
August 1, 2006;
12(15):
4702 - 4713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Farrow, L. B. Barrett, M. Stevenson, K. D. Fisher, J. Finn, R. Spice, M. A. Allan, M. Berry, A. Logan, L. W. Seymour, et al.
Cytoplasmic expression systems triggered by mRNA yield increased gene expression in post-mitotic neurons
Nucleic Acids Res.,
July 11, 2006;
34(11):
e80 - e80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vaysse, R. Harbottle, B. Bigger, A. Bergau, O. Tolmachov, and C. Coutelle
Development of a Self-assembling Nuclear Targeting Vector System Based on the Tetracycline Repressor Protein
J. Biol. Chem.,
February 13, 2004;
279(7):
5555 - 5564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tolmachova, R. Anders, J. Stinchcombe, G. Bossi, G. M. Griffiths, C. Huxley, and M. C. Seabra
A General Role for Rab27a in Secretory Cells
Mol. Biol. Cell,
January 1, 2004;
15(1):
332 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|